FDA Warning Letter — Sri Krishna Pharmaceuticals Limited
The FDA took a Warning Letter action against Sri Krishna Pharmaceuticals Limited on April 1, 2016 (Hyderabad, India). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Sri Krishna Pharmaceuticals Limited
- Date
- April 1, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Hyderabad (India)